The Food and Drug Administration will be holding a virtual public meeting on Friday, March 5, 2021, from 9:00 a.m. to 4:00 p.m. EST to highlight strategies to support rare disease product development. Please visit the public meeting page to register for the event.
To learn more about other activities relevant to rare diseases and listen to stories from the rare disease community and FDA staff working on rare diseases, please visit this webpage.